First human trial of monoclonal antibody to prevent malaria opens
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. ...
Jan 27, 2020
0
4